Litcius/Paper detail

Covid-19: European countries suspend use of Oxford-AstraZeneca vaccine after reports of blood clots

Jacqui Wise

2021BMJ350 citationsDOIOpen Access PDF

Abstract

Covid-19: European countries suspend use of Oxford-AstraZeneca vaccine after reports of blood clots Jacqui WiseDenmark has temporarily suspended use of the Oxford-AstraZeneca covid-19 vaccine as a precautionary move after reports of blood clots and one death.However, the European Medicines Agency (EMA) and the UK's regulatory body have said that there is no indication that vaccination is linked to thromboembolic events.Eight other countries-Norway, Iceland, Austria, Estonia, Lithuania, Luxembourg, Italy, and Latvia-have also suspended use of AstraZeneca's vaccine.The decisions are a further setback for Europe's vaccination campaign, which has struggled to pick up speed, partly because of delays in delivering the AstraZeneca vaccine.

Topics & Concepts

VaccinationCoronavirus disease 2019 (COVID-19)MedicineSetbackEuropean regionFunding AgencyAgency (philosophy)Family medicineVirologyPolitical scienceGeographyLawInternal medicinePublic relationsSociologyDiseaseRegional scienceSocial scienceInfectious disease (medical specialty)Heparin-Induced Thrombocytopenia and ThrombosisSARS-CoV-2 and COVID-19 Research